Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
28,000
Employees28,000
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
28,000
Employees28,000

AMGN Key Statistics

Market cap
153.05B
Market cap153.05B
Price-Earnings ratio
23.29
Price-Earnings ratio23.29
Dividend yield
3.25%
Dividend yield3.25%
Average volume
2.32M
Average volume2.32M
High today
$289.25
High today$289.25
Low today
$281.69
Low today$281.69
Open price
$287.35
Open price$287.35
Volume
2.46M
Volume2.46M
52 Week high
$339.17
52 Week high$339.17
52 Week low
$253.30
52 Week low$253.30

AMGN News

Benzinga 1d
Why Is Amgen Stock Falling Wednesday? - Amgen - Benzinga

...

Why Is Amgen Stock Falling Wednesday? - Amgen - Benzinga
Seeking Alpha 2d
Amgen in charts: Key drug sales drop in Q2, but Otezla sees continued growth

Earnings News Healthcare Amgen in charts: Key drug sales drop in Q2, but Otezla sees continued growth Aug. 06, 2025 1:17 AM ET Amgen Inc. (AMGN) Stock By: Arun...

Amgen in charts: Key drug sales drop in Q2, but Otezla sees continued growth
Seeking Alpha 2d
Amgen beat Q2 revenue and profit, stock trades flat

Amgen (NASDAQ:AMGN) reported second quarter earnings above expectations for the fourth time in a row, while also posting a revenue beat, helped by strong demand...

Amgen beat Q2 revenue and profit, stock trades flat

Analyst ratings

48%

of 33 ratings
Buy
48.5%
Hold
45.5%
Sell
6.1%

More AMGN News

Seeking Alpha 2d
Amgen Non-GAAP EPS of $6.02 beats by $0.74, revenue of $9.18B beats by $270M

Earnings News Amgen Non-GAAP EPS of $6.02 beats by $0.74, revenue of $9.18B beats by $270M Aug. 05, 2025 4:02 PM ET Amgen Inc. (AMGN) Stock By: Gaurav Batavia,...

Amgen Non-GAAP EPS of $6.02 beats by $0.74, revenue of $9.18B beats by $270M

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.
Eli Lilly
AbbVie
Merck
Chevron
Johnson & Johnson
JPMorgan Chase
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.